SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0000950170-24-059516
Filing Date
2024-05-14
Accepted
2024-05-14 16:05:54
Documents
69
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A evok-20231231.htm   iXBRL 10-K/A 2168941
2 EX-10.11 evok-ex10_11.htm EX-10.11 581992
3 EX-23.1 evok-ex23_1.htm EX-23.1 4990
4 EX-31.1 evok-ex31_1.htm EX-31.1 13856
5 EX-32.1 evok-ex32_1.htm EX-32.1 9087
6 EX-97 evok-ex97.htm EX-97 34620
7 GRAPHIC img215285054_0.jpg GRAPHIC 24883
8 GRAPHIC img215285054_1.jpg GRAPHIC 194336
  Complete submission text file 0000950170-24-059516.txt   9767834

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT evok-20231231.xsd EX-101.SCH 1194758
73 EXTRACTED XBRL INSTANCE DOCUMENT evok-20231231_htm.xml XML 1427207
Mailing Address 420 STEVENS AVENUE SUITE 370 SOLANA BEACH CA 92075
Business Address 420 STEVENS AVENUE SUITE 370 SOLANA BEACH CA 92075 858-345-1494
Evoke Pharma Inc (Filer) CIK: 0001403708 (see all company filings)

IRS No.: 208447886 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-36075 | Film No.: 24944245
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)